AstraZeneca: Key support at 7766p
Nicolas Suiffet November 23, 2020 7:22 PM
AstraZeneca reported: "Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19".
AstraZeneca, the global biopharmaceutical company, reported: "Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine."
From a chartist point of view, the stock price remains in consolidation mode. A key support base has formed at 7766p. In addition, a counterattack line pattern took shape on the 20th of November. The daily RSI (14) has landed on a support around 30% and is reversing up. The 50DMA started to flatten out. As long as 7766 is support, a rebound is expected towards the upper end of the consolidation range at 8848p. Caution: a break below 7766p would call for a reversal down trend towards 7121 (gap).
Source: GAIN Capital, TradingView
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.